Summary
Interactions of tolbutamide and glibenclamide with B cell adrenoceptors have been reported. This study evaluated the possible role of such interactions in the stimulation of insulin release. Mouse islets were incubated in the presence of 10 mmol/l glucose alone or with tolbutamide (10 μmol/l) or glibenclamide (0.02 μmol/l). At 0.01–10 μmol/l, blockers of α2-adrenoceptors (yohimbine, idazoxan) or α1-adrenoceptors (prazosin) had practically no effect on glucose-induced insulin release and did not affect its potentiation by sulphonylureas, except for a slight increase by 10 μmol/l prazosin and idazoxan. Nonspecific α-blockers (phentolamine, dihydroergotamine) increased control release at 10 μmol/l, but only the latter amplified the response to tolbutamide. Blockers of β-adrenoceptors were tested at 0.1–100 μmol/l: propranolol (β1, β2), metoprolol (β1) and compound ICI 118-551 (β2). They increased glucose-induced insulin release at 100 μmol/l but variably altered the effect of sulphonylureas. Blockers of adrenoceptors have, thus, no effect on insulin release in vitro at therapeutic concentrations. At high concentrations, they non-specifically affect the action of sulphonylureas. We conclude that an interaction with B cell adrenoceptors is not involved in the insulinotropic action of sulphonylureas.
Article PDF
Similar content being viewed by others
References
Cherksey B, Altszuler N (1984) Tolbutamide and glyburide differ in effectiveness to displace α- and β-adrenergic radioligands in pancreatic islet cells and membranes. Diabetes 33: 499–503
Massara F, Strumia E, Camanni F, Molinatti GM (1971) Depressed tolbutamide-induced insulin response in subjects treated with propranolol. Diabetologia 7: 287–289
Sirek A, Sirek OV, Policova Z (1974) Dihydroergotamine: a potent biological amplifier of sulphonylureas. Diabetologia 10: 267–270
Sirek OV, Sirek A, Policova Z (1975) Inhibition of sulphonylurea-stimulated insulin secretion by beta adrenergic blockade. Diabetologia 11: 269–272
Hampshire J, Moraru E, Rathgeb I, Schwarte J, Altszuler N (1978) Phentolamine potentiates tolbutamide-induced insulin secretion and hypoglycemia. Fed Proc 37: 628
Reynolds JEF (ed) (1989) Martindale — The extra pharmacopoeia. The Pharmaceutical Press, London, pp 1–1896
Henquin JC, Lambert AE (1975) Cobalt inhibition of insulin secretion and calcium uptake by isolated rat islets. Am J Physiol 228: 1669–1677
Nakaki T, Nakadate T, Kalo R (1980) α2-adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn-Schmiedeberg's Arch Pharmacol 313: 151–153
Cherksey B, Mendelsohn S, Zadunaisky J, Altszuler N (1982) Demonstration of α2-adrenergic receptors in rat pancreatic islets using radioligand binding. Proc Soc Exp Biol Med 171: 196–200
Fyles JM, Cawthorne MA, Howell SL (1986) The characteristics of β-adrenergic binding sites on pancreatic islets of Langerhans. J Endocrinol 111: 263–270
Schuit FC, Pipeleers DG (1986) Differences in adrenergic recognition by pancreatic A and B cells. Science 232: 875–877
Drews G, Debuyser A, Nenquin M, Henquin JC (1990) Galanin and epinephrine act on distinct receptors to inhibit insulin release by the same mechanisms including an increase in K+ permeability of the B-cell membrane. Endocrinology 126
Efendic S, Cerasi E, Luft R (1975) Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats. Diabetologia 11: 407–410
Northrop G, Ryan WG, Schwartz TB (1973) Propranolol-induced insulin release in isolated rat islets of Langerhans. Diabetes 22: 91–93
Schulz A, Hasselblatt A (1988) Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedeberg's Arch Pharmacol 337: 637–643
Henquin JC (1980) Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia 18: 151–160
Garrino MG, Schmeer W, Nenquin M, Meissner HP, Henquin JC (1985) Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia 28: 697–703
Sturgess NC, Ashford MLJ, Cook DL, Hales CN (1985) The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet II: 474–475
Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, Zünkler BJ, Lenzen S (1989) Control of insulin secretion by sulphonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol 38: 1217–1229
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garrino, M.G., Henquin, J.C. B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets. Diabetologia 33, 145–147 (1990). https://doi.org/10.1007/BF00404040
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404040